Pay in 4 interest-free payments of $2.50 Learn more
Ships within 48 hours · Estimated delivery Nov 18 - Nov 23
8% Intl growth 42% Indian share 18% Social Bonds $850M (4
This approach ensures that healthcare professionals can readily access and utilize Infermedica's diagnostic tools
raising sales for acquired brands by 30% in 2024
reflecting a mature market share among top-tier carriers
They process extensive datasets
ACCOLADE PORTER'S FIVE FORCES TEMPLATE RESEARCH B_183 8% Intl growth 42% IndianDon't Miss the Bigger Picture Accolade faces moderate buyer leverage and rising competitive pressure from digital health platforms, while supplier influence and regulatory shifts shape margins and growth prospects; substitute threats remain manageable but evolving with telehealth innovation. This brief snapshot only scratches the surface unlock the full Porter's Five Forces Analysis to explore Accolade's competitive dynamics, market pressures, and
US$ 466.50
US$ 430.00
US$ 57.00
US$ 313.50
US$ 103.50
US$ 6595.00
US$ 2609.00
